Skip to content

Verification of the anti-inflammatory effect with new PMMA dialyzer "NF" -CNW multicenter trial-

Verification of the anti-inflammatory effect with new PMMA dialyzer "NF" -CNW multicenter trial- - CNW multicenter trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016567
Enrollment
37
Registered
2015-03-01
Start date
2014-06-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

Group 1: Dialyzer was changed to &quot
. Group 2: Dialyzer was continued in the conventional PS membrane

Sponsors

JCHO Chiba Hospital
Lead Sponsor
HIMAWARI CLINIC SATO CLINIC MOBARA CLINIC OHARA CLINIC
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ?Three times a week of maintenance dialysis therapy ?Using polysulfone membranes ?Chronic inflammation (0.2mg / dL =< CRP < 2.0mg / dL)

Exclusion criteria

Exclusion criteria: ?Within one year from dialysis ?The elderly over 80 years of age at the time of the evaluation start ?Alb concentration is below 3.0g / dL ?The events of brain / heart region occured within the past 3 months ?With an inflammatory disease obviously ?With an active infection clearly

Design outcomes

Primary

MeasureTime frame
Lowering of CRP concentration

Secondary

MeasureTime frame
Improvements such as nPCR, %CGR, MNA, dialysis itching, treatment frequency with blood pressure lowering, blood components

Countries

Japan

Contacts

Public ContactKatsumi Okazawa

JCHO Chiba Hospital Clinical engineering

okazawa@jb3.so-net.ne.jp043-261-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026